首页> 美国卫生研究院文献>Journal of Personalized Medicine >Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
【2h】

Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1

机译:轻度认知障碍患者的靶向营养干预:认知障碍研究(CARES)试验1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Omega-3 fatty acids (ω-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals. Therefore, it is likely that these individuals will benefit from targeted nutritional intervention, given that poor nutrition is one of the many modifiable risk factors for MCI. Evidence to date suggests that these nutritional compounds can work independently to optimize the neurocognitive environment, primarily due to their antioxidant and anti-inflammatory properties. To date, however, no interventional studies have examined the potential synergistic effects of a combination of ω-3FAs, carotenoids and vitamin E on the cognitive function of patients with MCI. Individuals with clinically confirmed MCI consumed an ω-3FA plus carotenoid plus vitamin E formulation or placebo for 12 months. Cognitive performance was determined from tasks that assessed global cognition and episodic memory. Ω-3FAs, carotenoids, and vitamin E were measured in blood. Carotenoid concentrations were also measured in tissue (skin and retina). Individuals consuming the active intervention ( = 6; median [IQR] age 73.5 [69.5–80.5] years; 50% female) exhibited statistically significant improvements ( < 0.05, for all) in tissue carotenoid concentrations, and carotenoid and ω-3FA concentrations in blood. Trends in improvements in episodic memory and global cognition were also observed in this group. In contrast, the placebo group ( = 7; median [IQR] 72 (69.5–75.5) years; 89% female) remained unchanged or worsened for all measurements ( > 0.05). Despite a small sample size, this exploratory study is the first of its kind to identify trends in improved cognitive performance in individuals with MCI following supplementation with ω-3FAs, carotenoids, and vitamin E.
机译:Omega-3脂肪酸(ω-3FAs),类胡萝卜素和维生素E是健康饮食的重要组成部分。虽然它们存在于脑组织中,但研究表明,与认知健康的个体相比,患有轻度认知障碍(MCI)的个体中的这些关键营养素被消耗掉了。因此,鉴于营养不良是MCI的许多可改变的危险因素之一,因此这些人可能会受益于有针对性的营养干预。迄今为止的证据表明,这些营养化合物可以独立发挥作用,以优化神经认知环境,这主要是由于它们具有抗氧化和抗炎特性。然而,迄今为止,还没有干预研究检查过ω-3FA,类胡萝卜素和维生素E组合对MCI患者认知功能的潜在协同作用。临床确诊的MCI患者食用ω-3FA加类胡萝卜素加维生素E制剂或安慰剂治疗12个月。认知表现是通过评估整体认知和情节记忆的任务确定的。在血液中测量了Ω-3FA,类胡萝卜素和维生素E。还测量了组织(皮肤和视网膜)中的类胡萝卜素浓度。接受积极干预的个体(= 6;中位[IQR]年龄为73.5 [69.5-80.5]岁;女性为50%)在组织类胡萝卜素浓度以及类胡萝卜素和ω-3FA浓度方面具有统计学上的显着改善(对于所有情况,均<0.05)。血液。在该组中还观察到了情节记忆和整体认知的改善趋势。相比之下,安慰剂组(= 7;中位[IQR] 72岁(69.5-75.5)岁;女性89%)在所有测量中均保持不变或恶化(> 0.05)。尽管样本量很小,但这项探索性研究尚属首次,旨在确定在补充ω-3FA,类胡萝卜素和维生素E后MCI患者认知能力改善的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号